Early identification of dementia in the early or late stages of mild cognitive impairment (MCI) is crucial for a timely diagnosis and slowing down the progression of Alzheimer’s disease (AD). Positron emission tomography (PET) is considered a highly powerful diagnostic biomarker, but few approaches investigated the efficacy of focusing on localized PET-active areas for classification purposes. In this work, we propose a pipeline using learned features from semantically labelled PET images to perform group classification. A deformable multimodal PET-MRI registration method is employed to fuse an annotated MNI template to each patient-specific PET scan, generating a fully labelled volume from which 10 common regions of interest used for AD di...
Introduction. Various biomarkers have been reported in recent literature regarding imaging abnormali...
Objectives: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most c...
Alzheimer's Disease (AD) is a major concern for the elderly population, currently affecting over 670...
ABSTRACT: Early identification of dementia in the early or late stages of mild cognitive impairment ...
Alzheimer’s Disease (AD) is a widespread neurodegenerative disease. The disease causes brain atrophy...
International audienceThe analysis of positron emission tomography (PET) scan image is challenging d...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder, characterised by memory los...
The analysis of positron emission tomography (PET) scan image is challenging due to a high level of ...
Dementia is a chronic neurodegenerative disease impacting millions of elderlies globally every singl...
Alzheimer’s disease (AD), the most common cause of dementia, affects more than 520,000 people in the...
International audienceUsing a single imaging modality to diagnose Alzheimer's Disease (AD) or Mild C...
International audienceAlzheimer's Disease (AD), one of the main causes of death in elderly people, i...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder, characterised by memory loss...
Various biomarkers have been reported in recent literature regarding imaging abnormalities in differ...
Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose...
Introduction. Various biomarkers have been reported in recent literature regarding imaging abnormali...
Objectives: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most c...
Alzheimer's Disease (AD) is a major concern for the elderly population, currently affecting over 670...
ABSTRACT: Early identification of dementia in the early or late stages of mild cognitive impairment ...
Alzheimer’s Disease (AD) is a widespread neurodegenerative disease. The disease causes brain atrophy...
International audienceThe analysis of positron emission tomography (PET) scan image is challenging d...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder, characterised by memory los...
The analysis of positron emission tomography (PET) scan image is challenging due to a high level of ...
Dementia is a chronic neurodegenerative disease impacting millions of elderlies globally every singl...
Alzheimer’s disease (AD), the most common cause of dementia, affects more than 520,000 people in the...
International audienceUsing a single imaging modality to diagnose Alzheimer's Disease (AD) or Mild C...
International audienceAlzheimer's Disease (AD), one of the main causes of death in elderly people, i...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder, characterised by memory loss...
Various biomarkers have been reported in recent literature regarding imaging abnormalities in differ...
Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose...
Introduction. Various biomarkers have been reported in recent literature regarding imaging abnormali...
Objectives: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most c...
Alzheimer's Disease (AD) is a major concern for the elderly population, currently affecting over 670...